- Lenograstim
Drugbox
IUPAC_name =
CAS_number =
ATC_prefix = L03
ATC_suffix = AA10
PubChem =
DrugBank =
chemical_formula =
molecular_weight =
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =Lenograstim is a
recombinant granulocyte colony-stimulating factor which functions as aimmunostimulator .cite journal |author=Amadori S, Suciu S, Jehn U, "et al" |title=Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study |journal=Blood |volume=106 |issue=1 |pages=27–34 |year=2005 |pmid=15761020 |doi=10.1182/blood-2004-09-3728] It is developed by Merck & Co. under the brand name Koval.References
Wikimedia Foundation. 2010.